Christopher Maisel
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 18
- Multiple Myeloma Research and Treatments 15
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Oncology 11
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 2
- CAR-T cell therapy research 2
- Co-authors
- Joseph W. Fay (2 shared papers)Stanton L. Gerson (1 shared paper)Lili Liu (1 shared paper)Scot C. Remick (1 shared paper)Nizar Jacques Bahlis (4 shared papers)Pingfu Fu (1 shared paper)Estil A. Vance (2 shared papers)Houston Eccleston Holmes (2 shared papers)
- Journals
- Blood (8 papers)HemaSphere (2 papers)Journal of Clinical Oncology (1 paper)The Oncologist (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Christopher Maisel
18 papers receiving 273 citations
Peers
Comparison fields: 5 of 37
- Hematology 175
- Oncology 112
- Molecular Biology 133
- Radiology, Nuclear Medicine and Imaging 40
- Genetics 18
Countries citing papers authored by Christopher Maisel
This map shows the geographic impact of Christopher Maisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Maisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Maisel more than expected).
Fields of papers citing papers by Christopher Maisel
This network shows the impact of papers produced by Christopher Maisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Maisel. The network helps show where Christopher Maisel may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Maisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 127 | |
| 2 | 2022 | 44 | |
| 3 | 2011 | 28 | |
| 4 | 2007 | 26 | |
| 5 | 2020 | 11 | |
| 6 | 2021 | 11 | |
| 7 | 2006 | 9 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2019 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2014 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 1 |
About Christopher Maisel
Christopher Maisel is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 18 papers that have together received 284 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (8 papers), Peptidase Inhibition and Analysis (7 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers), CAR-T cell therapy research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (175 citations), Oncology (112 citations), Molecular Biology (133 citations), Radiology, Nuclear Medicine and Imaging (40 citations) and Genetics (18 citations). Christopher Maisel has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Joseph W. Fay, Stanton L. Gerson, Lili Liu, Scot C. Remick, Nizar Jacques Bahlis, Pingfu Fu, Estil A. Vance, Houston Eccleston Holmes, Giovanna Saracino and Barry Cooper. Their work appears in journals such as Blood, HemaSphere, Journal of Clinical Oncology, The Oncologist and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.